Costco's Mifepristone Exit Sparks 0.15% Rally, Stock Ranks 41st in $1.64B Trading Volume

On August 19, 2025, Costco (COST) rose 0.15% with a trading volume of $1.64 billion, ranking 41st in daily trading activity. The stock’s performance followed a decision by the retail giant to exclude mifepristone, the abortion pill, from its pharmacy inventory. Costco cited “lack of demand from members and other patients” as the rationale, aligning with its broader strategy to avoid politicized business decisions. The move drew criticism from New York City Comptroller Brad Lander, who called it “disappointing and short-sighted,” while pro-life advocacy groups hailed it as a victory.

The decision reflects Costco’s cautious approach to navigating the contentious legal and political landscape surrounding mifepristone. After the FDA relaxed in-person dispensing requirements in 2023, competitors like CVS and Walgreens secured certification to sell the drug. However, Costco faced sustained pressure from activist investors and coalitions urging it to follow suit. Inspire Investing, a faith-based investor group, coordinated efforts including shareholder letters, petitions, and media campaigns, emphasizing the reputational and financial risks of entering the abortion pill market. Costco’s leadership highlighted the absence of material demand and the potential to alienate its customer base as key factors in its stance.

Analysts noted the decision’s alignment with Costco’s brand identity as a family-focused retailer. The company’s emphasis on long-term customer relationships and avoidance of divisive political issues resonated with its core values. While critics argued the move could limit access to reproductive healthcare, Costco’s management reiterated its commitment to prioritizing member needs and operational stability. The stock’s modest gain suggests investor approval of the decision, though broader market dynamics and regulatory developments for mifepristone remain a watchpoint.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns, with a 10.5% gain. While the strategy captured some volatility, it also faced significant drawdowns, highlighting the importance of risk management in such a high-turnover approach.